Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg EP News Bureau Nov 12, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of…
Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg EP News Bureau Dec 1, 2023 Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable,…
Alembic Pharma receives US FDA tentative approval for Ivabradine tablets EP News Bureau Apr 20, 2022 The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Corlanor tablets, 5 mg and…
